The cognitive profiles of CADASIL and sporadic small vessel disease

R A Charlton1, R G Morris, A Nitkunan

  • 1Clinical Neuroscience, St. George's University of London, UK.

Neurology
|May 24, 2006
PubMed

Insights

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and small vessel disease (SVD) patients exhibit similar cognitive deficits, supporting CADASIL as a pure vascular dementia model. This research aids understanding of vascular dementia progression.

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Vascular dementia research is complicated by coexisting Alzheimer disease pathology.
  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetic condition causing pure vascular dementia, free from Alzheimer disease confounding.
  • Validating CADASIL as a pure vascular dementia model requires demonstrating similar cognitive impairments to other forms of vascular dementia.

Purpose of the Study:

  • To compare the cognitive profiles of patients with CADASIL and sporadic small vessel disease (SVD).
  • To assess the utility of CADASIL as a model for pure vascular dementia.
  • To investigate the cognitive impact of stroke in CADASIL patients.

Main Methods:

  • Neuropsychological assessments were administered to patients with CADASIL (n=34), SVD (n=54), and healthy controls (n=25).
  • Patients with CADASIL included those with and without stroke.
  • SVD patients presented with lacunar stroke and confluent leukoaraiosis.

Main Results:

  • Both CADASIL and SVD groups showed significant executive dysfunction compared to controls.
  • Impairments in executive function, specifically on the Trails switching test and verbal fluency, were observed in both CADASIL and SVD patients.
  • The SVD group also exhibited deficits in immediate and delayed memory recall.

Conclusions:

  • CADASIL and SVD present with comparable patterns of cognitive deficits, particularly executive dysfunction.
  • These findings support the use of CADASIL as a relevant model for studying pure vascular dementia.
  • CADASIL provides a valuable research tool for understanding sporadic small vessel disease-related vascular dementia.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...